Related Experiment Video
Updated: Jun 17, 2026
06:27
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study
Dwarakanathan Ranganathan1, Julie M Varghese, Robert G Fassett
1Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, 4029 Australia. Dwarakanathan_Ranganathan@health.qld.gov.au
BMC Nephrology
|December 17, 2009
Summary
This study investigates gentamicin pharmacokinetics in peritoneal dialysis (PD) patients with peritonitis. It aims to optimize intraperitoneal gentamicin dosing to enhance bacterial killing and reduce toxicity risks in PD patients.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Peritonitis is a major complication of peritoneal dialysis (PD).
- Intraperitoneal antibiotic delivery aims for maximal local drug concentration but risks systemic absorption and toxicity.
- Kidney function significantly impacts drug accumulation and toxicity risk in PD patients.
Purpose of the Study:
- To examine gentamicin pharmacokinetics in PD patients with peritonitis.
- To develop an optimized intraperitoneal gentamicin dosing regimen.
- To maximize bacterial killing while minimizing drug toxicity.
Main Methods:
- Observational pharmacokinetic study of PD patients with peritonitis.
- Patients categorized into anuric (Group 1) and non-anuric (Group 2) based on urine output.
- Gentamicin dosing follows current International Society for Peritoneal Dialysis guidelines; serial blood and dialysate levels monitored.
Main Results:
- The study describes gentamicin pharmacokinetics in PD patients with peritonitis.
- Data on drug absorption, distribution, and elimination via peritoneal route is collected.
- Analysis of blood and dialysate concentrations provides insights into drug exposure.
Conclusions:
- The study will inform improved dosing recommendations for intraperitoneal gentamicin in PD peritonitis.
- Findings will assist clinicians and pharmacists in selecting optimal gentamicin dosing regimens.
- Enhanced dosing strategies aim to improve treatment outcomes for PD-associated peritonitis.
Related Concept Videos
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
01:30Peritoneal Dialysis I: Introduction and Procedure
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
01:25Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...